| Dr.Evil vs Jin | 19–1 | 95.00% |
| Dr.Evil vs Law | 17–0 | 100.00% |
| Dr.Evil vs King | 13–1 | 92.86% |
| Dr.Evil vs Leo | 12–1 | 92.31% |
| Dr.Evil vs Nina | 10–1 | 90.91% |
| Dr.Evil vs Reina | 8–1 | 88.89% |
| Dr.Evil vs Eddy | 8–0 | 100.00% |
| Dr.Evil vs Fahkumram | 7–1 | 87.50% |
| Dr.Evil vs Yoshimitsu | 6–0 | 100.00% |
| Dr.Evil vs Bryan | 6–0 | 100.00% |
| Dr.Evil vs Dragunov | 4–2 | 66.67% |
| Dr.Evil vs Lars | 5–1 | 83.33% |
| Dr.Evil vs Alisa | 4–2 | 66.67% |
| Dr.Evil vs Xiaoyu | 5–0 | 100.00% |
| Dr.Evil vs Lidia | 5–0 | 100.00% |
| Dr.Evil vs Paul | 4–0 | 100.00% |
| Dr.Evil vs Jack-8 | 3–1 | 75.00% |
| Dr.Evil vs Asuka | 4–0 | 100.00% |
| Dr.Evil vs Lili | 4–0 | 100.00% |
| Dr.Evil vs Jun | 3–1 | 75.00% |
| Dr.Evil vs Azucena | 3–1 | 75.00% |
| Dr.Evil vs Hwoarang | 1–2 | 33.33% |
| Dr.Evil vs Claudio | 3–0 | 100.00% |
| Dr.Evil vs Zafina | 3–0 | 100.00% |
| Dr.Evil vs Victor | 3–0 | 100.00% |
| Dr.Evil vs Raven | 2–1 | 66.67% |
| Dr.Evil vs Anna | 1–2 | 33.33% |
| Dr.Evil vs Steve | 0–2 | 0.00% |
| Dr.Evil vs Devil Jin | 2–0 | 100.00% |
| Dr.Evil vs Feng | 2–0 | 100.00% |
| Dr.Evil vs Shaheen | 2–0 | 100.00% |
| Dr.Evil vs Lee | 2–0 | 100.00% |
| Dr.Evil vs Kuma | 2–0 | 100.00% |
| Dr.Evil vs Leroy | 1–1 | 50.00% |
| Dr.Evil vs Kazuya | 1–0 | 100.00% |
| Dr.Evil vs Heihachi | 1–0 | 100.00% |
| Dr.Evil vs Clive | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.